Unlocking Genomic Information in Tumor Biopsies

One of the founders of Canary Oncoceutics was part of a major cancer consortium of the Middle East focusing in genetic mutations in Arab cancers and whose work was performed at a major Research Hospital in Riyadh, KSA.

Canary’s comprehensive Acuity^TM DNA panel also tests for hundreds of variants - some of which are specific for drug sensitivity in this region.